Electrochemical and in silico approaches for liver metabolic oxidation of antitumor-active triazoloacridinone C-1305
5-Dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305) is a promising antitumor compound developed in our laboratory. A better understanding of its metabolic transformations is still needed to explain the multidirectional mechanism of pharmacological action of triazoloacridinone derivatives...
Saved in:
Main Authors: | Agnieszka Potęga (Author), Dorota Żelaszczyk (Author), Zofia Mazerska (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells
by: Anna Mieszkowska, et al.
Published: (2021) -
Novel insights into conjugation of antitumor-active unsymmetrical bisacridine C-2028 with glutathione: Characteristics of non-enzymatic and glutathione S-transferase-mediated reactions
by: Agnieszka Potęga, et al.
Published: (2021) -
European Fight Books 1305-1630: Classification, typology and comparison between manuscripts and prints
by: Daniel Jaquet
Published: (2020) -
Survey on the Current Status of Elderly Health Services in 1,305 Medical Institutions in Guangxi
by: Huang D, et al.
Published: (2024) -
MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway
by: Xiaoyong Wei, et al.
Published: (2019)